STERIS plc (NYSE:STE - Get Free Report) CFO Karen Burton sold 5,880 shares of the stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $255.62, for a total value of $1,503,045.60. Following the transaction, the chief financial officer directly owned 12,956 shares of the company's stock, valued at $3,311,812.72. The trade was a 31.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
STERIS Price Performance
NYSE STE traded down $2.77 during trading hours on Thursday, hitting $253.50. 503,989 shares of the company's stock traded hands, compared to its average volume of 773,021. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.05 and a quick ratio of 1.44. The firm's 50-day moving average is $222.09 and its 200-day moving average is $224.66. STERIS plc has a 52-week low of $195.14 and a 52-week high of $269.44. The company has a market capitalization of $24.62 billion, a PE ratio of 30.07 and a beta of 0.86.
STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share for the quarter, topping analysts' consensus estimates of $2.68 by $0.26. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the company posted $2.47 earnings per share. The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. Equities analysts forecast that STERIS plc will post 11.46 EPS for the current fiscal year.
STERIS Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Tuesday, November 17th will be given a dividend of $0.69 per share. The ex-dividend date of this dividend is Tuesday, November 17th. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.1%. STERIS's dividend payout ratio is currently 32.74%.
Analyst Ratings Changes
A number of research analysts recently issued reports on STE shares. KeyCorp lifted their target price on STERIS from $269.00 to $284.00 and gave the company an "overweight" rating in a report on Friday, November 6th. Piper Sandler restated an "overweight" rating and set a $275.00 price target (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Wall Street Zen lowered STERIS from a "strong-buy" rating to a "buy" rating in a research report on Sunday, October 11th. UBS Group decreased their price objective on STERIS from $275.00 to $270.00 and set a "buy" rating for the company in a research note on Friday, August 7th. Finally, Weiss Ratings raised STERIS from a "hold (c)" rating to a "hold (c+)" rating in a research report on Monday. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $276.33.
View Our Latest Stock Analysis on STE
Institutional Trading of STERIS
Several hedge funds and other institutional investors have recently made changes to their positions in STE. Wellington Management Group LLP grew its holdings in STERIS by 21.9% in the second quarter. Wellington Management Group LLP now owns 3,502,897 shares of the medical equipment provider's stock valued at $737,605,000 after purchasing an additional 629,532 shares during the last quarter. Janus Henderson Group PLC lifted its stake in shares of STERIS by 25.7% during the 1st quarter. Janus Henderson Group PLC now owns 1,863,139 shares of the medical equipment provider's stock worth $411,995,000 after purchasing an additional 380,504 shares during the period. Amundi boosted its stake in STERIS by 43.2% in the 1st quarter. Amundi now owns 771,092 shares of the medical equipment provider's stock worth $170,512,000 after buying an additional 232,520 shares during the last quarter. SEB Asset Management AB acquired a new position in shares of STERIS during the 1st quarter valued at about $30,660,000. Finally, Hsbc Holdings PLC increased its stake in shares of STERIS by 352.5% during the 1st quarter. Hsbc Holdings PLC now owns 176,320 shares of the medical equipment provider's stock valued at $38,958,000 after acquiring an additional 137,355 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.
STERIS Company Profile
(
Get Free Report)
STERIS plc NYSE: STE provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.